These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18037874)

  • 1. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
    Demicheli R; Retsky MW; Hrushesky WJ; Baum M
    Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy: separating observations from experimental science.
    Norton L
    Nat Clin Pract Oncol; 2007 Dec; 4(12):671. PubMed ID: 18037872
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence dynamics does not depend on the recurrence site.
    Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
    Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does surgery modify growth kinetics of breast cancer micrometastases?
    Demicheli R; Valagussa P; Bonadonna G
    Br J Cancer; 2001 Aug; 85(4):490-2. PubMed ID: 11506484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tumor resection improves the survival of younger patients with metastatic breast cancer.
    Shien T; Kinoshita T; Shimizu C; Hojo T; Taira N; Doihara H; Akashi-Tanaka S
    Oncol Rep; 2009 Mar; 21(3):827-32. PubMed ID: 19212646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer dormancy can be maintained by small numbers of micrometastases.
    Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
    Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
    Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL
    Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
    Hanin L; Bunimovich-Mendrazitsky S
    Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.
    Joensuu K; Heikkilä P; Andersson LC
    Cancer Lett; 2008 Jun; 265(1):76-83. PubMed ID: 18355956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
    Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
    Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary breast angiosarcoma: two case reports].
    Champeaux-Orange E; Bonneau C; Raharimanana B; Favre A; Ibrahim M; Breteau N
    Cancer Radiother; 2009 Jun; 13(3):209-12. PubMed ID: 19410492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
    Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
    Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.